Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Villalobos, A."'
Autor:
Rafael Villalobos-Molina, Eduardo Hernández-Vázquez, Hugo Ocampo-Montalban, Angélica Flores-Flores, Miguel Cruz, Guadalupe Hiriart-Valencia, Samuel Estrada-Soto, Jaime Gomez-Zamudio, Litzia Cerón-Romero
Publikováno v:
European journal of pharmacology. 803
Diabetes is a major health problem and a predisposition factor for further degenerative complications and, therefore, novel therapies are urgently needed. Currently, cannabinoid receptor 1 (CB1 receptor) antagonists have been considered as promissory
Autor:
Francisco J. Flores-Murrieta, Karla Lizet Beltrán-Villalobos, Rosa Mariana Montiel-Ruiz, Selene I. Patiño-Camacho, Dalia A. Castro-Vidal, Myrna Déciga Campos
Publikováno v:
European journal of pharmacology. 805
The aim of the present study was to determine whether tizanidine, an alpha2-adrenoceptor agonist, is able to increase the anti-inflammatory and anti-nociceptive effects of naproxen and ketorolac with a low incidence of gastric injury and spontaneous
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Roxana N. Peroni, Damasia Becu-Villalobos, Stella Maris Celuch, Juan Pablo Huidobro-Toro, Edda Adler-Graschinsky, Marı́a Luz Orliac
Publikováno v:
European Journal of Pharmacology. 493:151-160
Anandamide (0.01 to 10 microM) caused greater concentration-dependent reductions of the contractile-induced responses to noradrenaline in female than in male mesenteric vascular beds isolated from adult Sprague-Dawley rats. Greater relaxant responses
Autor:
A. Guerrero, José Antonio González-Correa, Felipe Sánchez de la Cuesta, M. M. Arrebola, José Pedro De La Cruz, M.A. Villalobos, Araceli Pinacho
Publikováno v:
European Journal of Pharmacology. 484:19-27
Clinical studies have shown that the ability of aspirin to prevent cerebrovascular accidents is weaker in patients with diabetes. The aim of this study was to determine whether high concentrations of glucose modified the effect of aspirin, ticlopidin
Autor:
Maximiliano Ibarra, J.Javier López-Guerrero, Rafael Villalobos-Molina, Itzell A. Gallardo-Ortiz
Publikováno v:
European Journal of Pharmacology. 455:59-64
The effect of NAN-190 (1-(2-methoxyphenyl)-4-[4-(2-phthalimido]-butyl] piperazine), described as a mixed 5-HT(1A) receptor agonist/antagonist, on cardiovascular function was studied. The i.v. injection of NAN-190 (1-300 micro/kg) dose-dependently dec
Publikováno v:
European Journal of Pharmacology. 351:49-52
The interaction between chloroethylclonidine (N-beta-chloroethyl-N-methylamino-methyl-clonidine) and alpha1-adrenoceptors mediating contraction in Wistar Kyoto rat arteries was examined. In caudal (alpha1A-adrenoceptors) and aorta (alpha1D-adrenocept
Autor:
Yoshinori Takei, Rafael Villalobos-Molina, Jean A. Castillo-Badillo, M. Teresa Romero-Ávila, Gozoh Tsujimoto, J. Adolfo García-Sáinz, Akira Hirasawa, Omar B. Sánchez-Reyes
Publikováno v:
European journal of pharmacology. 723
GPR120, free fatty acid receptor 4, is a recently deorphanized G protein-coupled receptor that seems to play cardinal roles in the regulation of metabolism and in the pathophysiology of inflammatory and metabolic disorders. In the present work a GPR1
Publikováno v:
European Journal of Pharmacology. 241:141-148
This study was designed to determine if α 1 -adrenoceptors are involved in the vascular responses to 5-HT 1A receptor agonists. Buspirone (3.1 × 10 −7 –3.1 × 10 −5 M) and 8-hydroxy-2(di-N-propylamino)tetralin (8-OH-DPAT; 3.1 × 10 −6 –10